Niox Group Regulatory News (NIOX)

NIOX Group plc

Director/PDMR Shareholding

29 March 2023

NIOX Group plc (the "Company") (AIM: NIOX) announced that on 28 March 2023 share awards were made in respect of their 2022 bonuses to Ian Johnson, Jonathan Emms and Michael Roller (the "Executive Directors"). These awards were made under the terms of the Deferred Share Bonus Plan (the "Plan"), which requires 50% of the shares awarded to be deferred for a two year period. The total awards made today under the Plan are as follows:

These awards are being partially satisfied by way of a transfer of 48,693 ordinary shares of 0.08 pence each in the Company ("Ordinary Shares") from the Circassia Pharmaceuticals plc Employee Benefit Trust (the "Trust") to the Executive Directors, with the balance of 583,275 Ordinary Shares being satisfied by way of an issue of new Ordinary Shares.

.

The following table shows the numbers of Ordinary Shares being awarded to the Executive Directors on the same day by way of the transfers from the Trust at nil cost and the issue of new Ordinary Shares at a value of 0.08 pence per share:

Under the rules of the Plan, each Executive Director is permitted to sell sufficient number of Ordinary Shares as may be needed to satisfy their tax liability arising on the award of the bonus. As a result, a total of 621,868 Ordinary Shares were sold on the same day on behalf of the Executive Directors.

Following these transactions, Ian Johnson holds 709,820 Ordinary Shares (0.17% of the issued share capital of the Company), Jonathan Emms holds 710,086 Ordinary Shares (0.17% of the issued share capital of the Company) and Michael Roller holds 500,122 Ordinary Shares (0.12% of the issued share capital of the Company).

Under the current remuneration policy, 50% of the bonus shares awarded are deferred for two years. It is therefore expected that on or around 28 March 2025, a further 631,968 Ordinary Shares will be issued to the Executive Directors. A further announcement will be made at the relevant time.

The 583,275 new Ordinary Shares issued in connection with these awards are subject to an existing block admission and rank pari passu with the existing ordinary shares of the Company.

Following the above, the Company's issued share capital now consists of 420,160,864 Ordinary Shares, each carrying one voting right. Therefore, the total number of voting rights in the Company is 420,160,864. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

Additional detail is provided below in accordance with the requirements of UK MAR.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them